EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,424,000 | -41.1% | 882,353 | -55.6% | 0.12% | -53.9% |
| Q1 2019 | $46,576,000 | +70.4% | 1,986,201 | 0.0% | 0.27% | +71.2% |
| Q4 2018 | $27,330,000 | +37.9% | 1,986,201 | 0.0% | 0.16% | +41.8% |
| Q3 2018 | $19,822,000 | -50.9% | 1,986,201 | 0.0% | 0.11% | -52.4% |
| Q2 2018 | $40,399,000 | – | 1,986,201 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |